Headlines about MetLife (NYSE:MET) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MetLife earned a news impact score of 0.12 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 46.9416681103762 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the headlines that may have effected Accern’s rankings:
- Equities Analysts Issue Forecasts for MetLife, Inc.’s Q3 2017 Earnings (MET) (americanbankingnews.com)
- MetLife, Inc. (MET) Earns Buy Rating from Langen Mcalenn (americanbankingnews.com)
- Of Vermont Increases Position in MetLife, Inc. (MET) (vothemes.com)
- MetLife, Inc. (MET) Shares Sold by Hartford Investment Management Co (techkenyot.com)
- MetLife, Inc. (MET) Receives $58.86 Consensus Target Price from Analysts (fishinghd.com)
MetLife (NYSE:MET) traded up 0.15% during trading on Friday, reaching $47.02. The company’s stock had a trading volume of 7,662,137 shares. The stock has a market cap of $49.98 billion, a P/E ratio of 553.18 and a beta of 1.46. The firm’s 50-day moving average is $48.77 and its 200-day moving average is $47.24. MetLife has a 52-week low of $35.72 and a 52-week high of $51.77.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 3.40%. MetLife’s dividend payout ratio (DPR) is currently 1,777.98%.
MET has been the topic of a number of recent research reports. TheStreet downgraded MetLife from a “b-” rating to a “c” rating in a research note on Tuesday, May 16th. ValuEngine upgraded MetLife from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Citigroup Inc. set a $51.00 price objective on MetLife and gave the stock a “sell” rating in a research report on Friday, July 7th. BidaskClub raised MetLife from a “strong sell” rating to a “sell” rating in a research report on Saturday, June 10th. Finally, Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research report on Thursday, May 4th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $59.17.
MetLife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.